CSL Behring har dedikeret sig til at redde liv og forbedre livskvaliteten for mennesker med sjældne og alvorlige sygdomme verden rundt
http://www.cslbehring.dk/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
0.8 seconds
16x16
32x32
64x64
128x128
160x160
192x192
PAGES IN
THIS WEBSITE
15
SSL
EXTERNAL LINKS
158
SITE IP
12.3.33.46
LOAD TIME
0.789 sec
SCORE
6.2
CSL Behring Danmark - Leverandør af plasmaprodukter baseret på dansk donor plasma | cslbehring.dk Reviews
https://cslbehring.dk
CSL Behring har dedikeret sig til at redde liv og forbedre livskvaliteten for mennesker med sjældne og alvorlige sygdomme verden rundt
cslbehring.dk
Fra dansk donor til dansk patient
http://www.cslbehring.dk/fra-dansk-donor-til-dansk-patient
Inkluder alle CSL Behrings regionale hjemmesider. Fra dansk donor til dansk patient. Fra dansk donor til dansk patient. Fra dansk donor til dansk patient. Denne hjemmeside anvender cookies. Du accepterer brugen af cookies ved at klikke videre på siden eller klikke OK. Du finder information om cookies, hvilke vi anvender og hvorfor vi gør brug af dem ved at klikke. De danske blodbanker modtager blod fra danske donorer, blodet anvendes til behandling af patienter på de danske hospitaler. Inden blodet k...
CSL Behring i Norden
http://www.cslbehring.dk/csl-behring-i-norden
Inkluder alle CSL Behrings regionale hjemmesider. Global forskning og produktudvikling. CSL Behring gennem tiden. CSL Behring i Norden. CSL Behring i Norden. Denne hjemmeside anvender cookies. Du accepterer brugen af cookies ved at klikke videre på siden eller klikke OK. Du finder information om cookies, hvilke vi anvender og hvorfor vi gør brug af dem ved at klikke. CSL Behrings produkter på det danske marked. CSL Behring ApS, Lyngby Hovedgade 70A 1, 2800 Kgs. Lyngby CVR-nr. 25361695.
Vi støtter
http://www.cslbehring.dk/vistotter
Inkluder alle CSL Behrings regionale hjemmesider. Global forskning og produktudvikling. CSL Behring gennem tiden. Denne hjemmeside anvender cookies. Du accepterer brugen af cookies ved at klikke videre på siden eller klikke OK. Du finder information om cookies, hvilke vi anvender og hvorfor vi gør brug af dem ved at klikke. World Federation of Hemophilia. CSL Behring donerer medicin til behandling af blødningsforstyrrelse. I 2009 indgik vi, som den første producent af plasmabaserede lægemidler, en treåri...
Patient
http://www.cslbehring.dk/patient
Inkluder alle CSL Behrings regionale hjemmesider. Fra dansk donor til dansk patient. Denne hjemmeside anvender cookies. Du accepterer brugen af cookies ved at klikke videre på siden eller klikke OK. Du finder information om cookies, hvilke vi anvender og hvorfor vi gør brug af dem ved at klikke. Hvis du lider af en sjælden og alvorlig sygdom, kan det være svært at få information om symptomer og behandling. Her kan du finde mere information. Fra dansk donor til dansk patient.
Patientforeninger
http://www.cslbehring.dk/patientforeninger
Inkluder alle CSL Behrings regionale hjemmesider. Fra dansk donor til dansk patient. Denne hjemmeside anvender cookies. Du accepterer brugen af cookies ved at klikke videre på siden eller klikke OK. Du finder information om cookies, hvilke vi anvender og hvorfor vi gør brug af dem ved at klikke. Hos CSL Behring ved vi, hvor vigtigt det er, at du kan tale med andre om sygdom, sorg, glæde og oplevelser. Her kan du finde forskellige foreninger, der står klar til at lytte og hjælpe. Du er ikke alene! Primær ...
TOTAL PAGES IN THIS WEBSITE
15
Von Willebrand Disease
http://www.cslbehring.se/s1/cs/bese/1252899238848/content/1252899231141/content.htm
Include All CSL Behring Country Sites. Physicians & Health Care Professionals. Patients & Families. Haemolytic disease of the newborn. Congenital Factor XIII Deficiency. People with von Willebrand disease. VWD) have a problem with one of the clotting factors in the blood; this particular clotting factor is known as von Willebrand factor. In people unaffected by von Willebrand disease, this clotting factor helps platelets stick to the wall of the damaged blood vessel and assists the glue-like clotting.
Immunoglobulin, IVIg & SCIg | CSL Behring
http://www.cslbehring.com/s1/cs/enco/1255923358055/page/1255923357721/TabsLandingPage.htm
All CSL Behring Web Sites. Health, Safety & Environment. Quality & Safety. CSL Research & Development. Other Areas of Business. CSL Behring offers one of the world's most comprehensive portfolios of safe, high quality, technically advanced immunoglobulin (Ig) products designed to offer patients the convenience, choice, and ease of administration that they seek. The body's immune system can then work more effectively. CSL Behring Immunoglobulin Products. The CSL Behring product portfolio includes key immu...
Physicians & Health Care Professionals
http://www.cslbehring.se/s1/cs/bese/1164719155492/content/1164719155034/content.htm
Include All CSL Behring Country Sites. Physicians & Health Care Professionals. CSL Behring Nordic VW Scholarship. Patients & Families. Physicians and Health Care Professionals. Physicians and Health-care Professionals. Welcome to our section for physicians and health-care professionals. Here you will find information about our medicinal products as well as access to scientific literature, and links to further relevant information. The Patient and Families. If you have any questions.
Privacy Policy
http://www.cslbehring.se/s1/cs/bese/1160484846607/content/1160484846331/content.htm
Include All CSL Behring Country Sites. Physicians & Health Care Professionals. Patients & Families. Thank you for visiting www.cslbehring.se. Information Collected from You. How to Contact Us. Information Collected from You. Only when you specifically request it will the information that we collect be used to respond to your questions, or to fulfill e-mail messaging programs, and notify visitors about new content or services on our Web sites. The domain and host from which you access the Internet. You ma...
CSL Behring
http://www.cslbehring.se/s1/cs/bese/1160484846586/page/1252899180566/HomepageTemplate.htm
Include All CSL Behring Country Sites. Physicians & Health Care Professionals. Patients & Families. CSL Behring is committed to improving the quality of life for patients with rare and serious diseases. The company develops, manufactures and markets a range of products for the following therapy areas:. Products for the treatment of Congenital FXIII Deficiency, Congenital Fibrinogen Deficiency, Haemophilia, Rapid Warfarin Reversal and von Willebrand Disease. Congenital Factor XIII Deficiency.
CSL Behring: Global Life Saving Biotherapies, Plasma Protein Biotherapeutics
http://www.cslbehring.com/s1/cs/enco/1151443990667/content/1151443991017/home.htm
All CSL Behring Web Sites. Health, Safety & Environment. Quality & Safety. CSL Research & Development. Other Areas of Business. CSL Behring develops, manufactures and markets protein based therapies, including:. Hereditary Angioedema (HAE) Therapies. Paul Perreault Talks About Innovation. Paul Perreault on Bloomberg News: "If you're not innovating in this rare disease space, you're planning your exit.". Tim’s Story: Outdoor Adventurer Remains Active Despite Hemophilia.
CSL completes Novartis influenza vaccine business acquisition
http://www.csl.com.au/Investors/CSL-Completes-Novartis-Influenza-Vaccine-Business-Acquisition.htm
CSL Plasma Services (Germany). R&D and Operational Briefings. CSL completes Novartis influenza vaccine business acquisition. CSL completes Novartis influenza vaccine business acquisition. CSL Limited (ASX:CSL; USOTC: CSLLY) today announced that it has now closed its transaction to acquire Novartis global influenza vaccine business for a cash consideration of US$275 million. As foreshadowed in CSL’s release to the Australian Securities Exchange on 31 July. For further information, please contact:.
CSL - Financial Reports
http://www.csl.com.au/investors/financial-reports.htm
CSL Plasma Services (Germany). R&D and Operational Briefings. Half Year Report 2015-2016. As CSL reaches a remarkable milestone this year, marking 100 years of developing and delivering innovations to help patients live life to the fullest, I am pleased to report an exceptional first half year result. For the six months ended 31 December 2015, CSL reported net profit after tax of US$719 million, an increase of US$27 million (4% on a reported basis) on the same period last year. Half Year Report 2015-2016.
CSL Behring: Professor Heimburger Award, Global Research Grant Coagulation
http://www.cslbehring.com/products/bleeding-disorders/professor-heimburger-award.htm
All CSL Behring Web Sites. Health, Safety & Environment. Quality & Safety. CSL Research & Development. Other Areas of Business. CSL Behring Prof. Heimburger Award. Global Research Grant Coagulation. Award Winners (2008 2015). For inquiries regarding applications, policy and procedures information, please contact:. T: 49 6421 394191. E-mail: heimburger.award@cslbehring.com. Prof Heimburger Award 2016:. Professor Dr. Norbert Heimburger. Due to his determination and his constant interaction with leading hem...
TOTAL LINKS TO THIS WEBSITE
158
Início
Incluir todos os Websites da CSL Behring no Mundo. Sobre a CSL Behring. Profissionais da Saúde e Médicos. CSL Behring oferece diversas terapias, derivadas do plasma e recombinantes, para o tratamento de distúrbios da coagulação. Veja todos os produtos. A CSL Behring fornece aos pacientes e seus familiares recursos e serviços desenvolvidos para fortalecer sua . Centros de hemofilia atualizado em abril de 2016. Centros de referência para o tratamento de imunodeficiência primária atualizado em abril de 2016.
公司首页
Pagina de Inicio
CSL Behring en el Mundo. Incluir todos los sitios de CSL Behring. Acerca de CSL Behring. Compromiso con el paciente. CSL Investigación y Desarrollo. Medicos y Profesionales de la Salud. Eventos adversos y Farmacovigilancia (México). Eventos adversos y Farmacovigilancia (Centroamerica, Caribe, Bolivia, Chile, Colombia, Ecuador, Paraguay, Peru, Uruguay, Venezuela). CSL Behring desarrolla fabrica y vende terapias basadas en proteinas, incluyendo:. Bienvenidos al Blog oficial de CSL Behring.
Home
Include All CSL Behring Country Sites. Quality & Safety. We develop and manufacture vaccines and plasma protein biotherapies. These products help treat and prevent serious human medical conditions. Read More. CSL’s strong business performance this year is underpinned by our new and improved therapies, entry to new markets . This section features all recent CSL Behring news releases. CSL Plasma Services Germany.
CSL Behring - Biotherapies for Life
Alle CSL Behring Webseiten einschließen. Qualität & Sicherheit. CSL Forschung & Entwicklung. Jobs & Karriere. CSL Behring - Biotherapies for Life. CSL Behring entwickelt, produziert und vertreibt Plasmaderivate für die Indikations- und Therapiebereiche:. Jobs bei CSL Behring in Marburg. CSL Behring bei YouTube. Folgen Sie CSL Behring auf unserem deutschen YouTube-Channel. Gerinnungsstörungen gezielt erkennen und behandeln. Hämostaseologisch verursachte Blutungen im Überblick.
CSL Behring Danmark - Leverandør af plasmaprodukter baseret på dansk donor plasma
Inkluder alle CSL Behrings regionale hjemmesider. Denne hjemmeside anvender cookies. Du accepterer brugen af cookies ved at klikke videre på siden eller klikke OK. Du finder information om cookies, hvilke vi anvender og hvorfor vi gør brug af dem ved at klikke. CSL Behring er en verdensomspændende virksomhed, der har fokus på at producere og udvikle produkter, der forbedrer livskvaliteten hos patienter med sjældne og alvorlige sygdomme. Læs mere her. CSL Behring støtter Hjerterytterne.
CSL Behring Home Page
Utilizamos cookies propias y de terceros para recopilar información estadística del uso de nuestra página web. Si continúa navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. Incluir todos los sitios de CSL Behring. Acerca de CSL Behring. CSL Behring Home Page. CSL Behring ha asumido el compromiso de salvar vidas y mejorar la calidad de vida de las personas con enfermedades raras y graves, en todo el mundo. Día Mundial de la Hemofilia 2018.
CSL Behring France: entreprise de biotechnologies (protéines thérapeutiques > traitement maladies rares et graves (hémophilie a et b, déficits immunitaires, etc.)).
Traitement maladies rares et graves (hémophilie a et b, déficits immunitaires, etc.) .'/. En poursuivant votre navigation sur ce site, vous acceptez l’utilisation de Cookies pour la réalisation de statistiques de visites. Pour en savoir plus et paramétrer les cookies. Tous les sites CSL Behring. Inclure tous les emplacements de pays de CSL Behring. A propos de CSL Behring. Engagement dans les maladies rares. Domaines thérapeutiques :. Déficits du système immunitaire. Déficits en facteur de coagulation.
CSL Behring - Biotherapies for life
In tutti i siti CSL Behring. Ordini di emergenza e modulistica. CSL Behring - Biotherapies for life. Official BLOG of CSL Behring. Canale YouTube CSL Behring Italia. Brochure Istituzionale CSL Behring. Agli standard di qualità EN ISO 9001:2008. Tutti i siti CSL Behring.
Homepage
Zoeken in alle CSL Behring-websites. CSL Behring zet zich in om wereldwijd levens te redden en de kwaliteit van leven te verbeteren van mensen met zeldzame en ernstige aandoeningen. CSL Behring neemt de gezondheid van de mensen die onze levensreddende therapieën gebruiken zeer serieus.
CSL Behring
Include All CSL Behring Country Sites. Physicians & Healthcare Professionals. Patients & Families. Physicians and Health Care Professionals. CSL Behring is committed to improving the quality of life for patients with rare and serious diseases. The company develops, manufactures and markets a range of products for the following therapy areas:. Products for the treatment of Congenital FXIII Deficiency, Congenital Fibrinogen Deficiency, Haemophilia, Rapid Warfarin Reversal and von Willebrand Disease.
